Anika Therapeutics | Ordinære Aktiekapital

Ordinary Share Capital Lave om Dato
Arrowhead Research USD 200K 0 2023-12
Halozyme Therapeutics USD 127K 5K 2023-12
Insmed USD 1.48M 50K 2023-12
Integra LifeSciences USD 909K 0 2023-12
Ligand Pharmaceuticals USD 18K 0 2023-12
Smith & Nephew USD 175M 0 2023-06
Veracyte USD 73K 0 2023-09
Xencor USD 611K 4K 2023-12



Anika Therapeutics Ordinære Aktiekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2024.